RT @JAXcancercenter: Commentary in @Cancer_Cell: challenges & opportunities in modeling #aging & #cancer. @OlgaAnczukow @jeffgenome… https://t.co/IRIE4k7Y4n

Many congratulations Tom! @RoswellPark is extremely proud https://t.co/VOtHqjDdTf

RT @Johanna_A_Joyce: "The evolving tumor microenvironment: From cancer initiation to metastatic outgrowth" Delighted to share our new r… https://t.co/7F4wf8Y1ji

For International Women’s Day, a tribute to Dr. Mary Ebos - doctorate in Women’s Studies, masters in Art History, f… https://t.co/IQEdDelLL9

Nature welcomes Registered Reports https://t.co/XEb4yC1w1k

Locally sourced: site-specific immune barriers to metastasis | Nature Reviews Immunology https://t.co/7VzPiC1zuf

RT @NatureRevCancer: NEW content online! Mechanisms driving the immunoregulatory function of cancer cells https://t.co/H4sw0Yrhoz https://t.co/7aze7lvPfy

RT @TrendsImmuno: TBK1 inhibition unleashes RIPK1, resensitizing tumors to immunotherapy https://t.co/ytkMFWenxM #immunology

RT @tompowles1: Hot Topics in GU in Canary Islands. The clear benefits for VEGF/PD1 combs vs sunitinib in good risk mRCC is less cl… https://t.co/smAAstkpzg

RT @MangusoLab: Our manuscript on targeting TBK1 to overcome resistance to ICB with the Jenkins lab @MGHCancerCenter is out online… https://t.co/zxL3yRfewE